Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

477 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
In Vitro and In Vivo Effects of the Urokinase Plasminogen Activator Inhibitor WX-340 on Anaplastic Thyroid Cancer Cell Lines.
Baldini E, Presutti D, Favoriti P, Santini S, Papoff G, Tuccilli C, Carletti R, Di Gioia C, Lori E, Ferent IC, Gagliardi F, Catania A, Pironi D, Tripodi D, D'Andrea V, Sorrenti S, Ruberti G, Ulisse S. Baldini E, et al. Among authors: catania a. Int J Mol Sci. 2022 Mar 28;23(7):3724. doi: 10.3390/ijms23073724. Int J Mol Sci. 2022. PMID: 35409084 Free PMC article.
PD-1 Ligand Expression in Epithelial Thyroid Cancers: Potential Clinical Implications.
Ulisse S, Tuccilli C, Sorrenti S, Antonelli A, Fallahi P, D'Armiento E, Catania A, Tartaglia F, Amabile MI, Giacomelli L, Metere A, Cornacchini N, Pironi D, Carbotta G, Vergine M, Monti M, Baldini E. Ulisse S, et al. Among authors: catania a. Int J Mol Sci. 2019 Mar 20;20(6):1405. doi: 10.3390/ijms20061405. Int J Mol Sci. 2019. PMID: 30897754 Free PMC article. Review.
High expression of the urokinase plasminogen activator and its cognate receptor associates with advanced stages and reduced disease-free interval in papillary thyroid carcinoma.
Ulisse S, Baldini E, Sorrenti S, Barollo S, Gnessi L, Catania A, Pellizzo MR, Nardi F, Mian C, De Antoni E, D'Armiento M, Frati L. Ulisse S, et al. Among authors: catania a. J Clin Endocrinol Metab. 2011 Feb;96(2):504-8. doi: 10.1210/jc.2010-1688. Epub 2010 Nov 24. J Clin Endocrinol Metab. 2011. PMID: 21106716
In papillary thyroid carcinoma BRAFV600E is associated with increased expression of the urokinase plasminogen activator and its cognate receptor, but not with disease-free interval.
Ulisse S, Baldini E, Sorrenti S, Barollo S, Prinzi N, Catania A, Nesca A, Gnessi L, Pelizzo MR, Mian C, De Vito C, Calvanese A, Palermo S, Persechino S, De Antoni E, D'Armiento M. Ulisse S, et al. Among authors: catania a. Clin Endocrinol (Oxf). 2012 Nov;77(5):780-6. doi: 10.1111/j.1365-2265.2012.04465.x. Clin Endocrinol (Oxf). 2012. PMID: 22702340
477 results